Literature DB >> 565264

Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis.

B J Maron, W H Merrill, P A Freier, K M Kent, S E Epstein, A G Morrow.   

Abstract

Long-term results of operation for IHSS were reviewed in 124 patients operated upon between 1960 and 1975. Most patients improved symptomatically and manifested marked reduction in LV outflow gradient at rest postoperatively. However, ten (8%) patients died of causes related to operation, 14 (12%) had persistent or recurrent severe functional limitation, and 11 (9%) died up to 13 years postoperatively due to hypertrophic cardiomyopathy. Overall annual mortality rate was 3.5% and was 1.8% for late deaths alone. Of 11 late postoperative deaths, six were sudden and five were due to chronic heart failure. Atrial fibrillation was significantly more common in patients who died late postoperatively than in survivors. Nine of the 11 late deaths had associated medical problems that may have contributed to their outcome. In conclusion, long-lasting clinical improvement occurred in most patients who survived operation for IHSS. However, 12% of patients deteriorated clinically over the 5.2 year average follow-up, and there is continued, small annual mortality.

Entities:  

Mesh:

Year:  1978        PMID: 565264     DOI: 10.1161/01.cir.57.6.1205

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  16 in total

1.  Ventricular dysfunction in hypertrophic obstructive cardiomyopathy.

Authors:  R D Leachman
Journal:  Tex Heart Inst J       Date:  1991

2.  Non-surgical ablation of the ventricular septum for the treatment of hypertrophic cardiomyopathy.

Authors:  C Knight; U Sigwart
Journal:  Heart       Date:  1996-07       Impact factor: 5.994

3.  Surgery for hypertrophic cardiomyopathy.

Authors:  James J Wu; Michael Seco; Caroline Medi; Chris Semsarian; David R Richmond; Joseph A Dearani; Hartzell V Schaff; Michael J Byrom; Paul G Bannon
Journal:  Biophys Rev       Date:  2015-01-10

Review 4.  The frontiers of cardiomyopathy.

Authors:  J F Goodwin
Journal:  Br Heart J       Date:  1982-07

5.  Surgical treatment of hypertrophic obstructive cardiomyopathy in the elderly.

Authors:  K Kafetz
Journal:  Postgrad Med J       Date:  1981-09       Impact factor: 2.401

6.  Obstruction of a Björk-Shiley mitral prosthesis in a patient with idiopathic hypertrophic subaortic stenosis.

Authors:  T Raychaudhury; A Faichney; P R Walbaum
Journal:  Thorax       Date:  1983-05       Impact factor: 9.139

7.  Dynamics of left ventricular ejection in obstructive and nonobstructive hypertrophic cardiomyopathy.

Authors:  J P Murgo; B R Alter; J F Dorethy; S A Altobelli; G M McGranahan
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

8.  Hypertrophic cardiomyopathy: an important cause of sudden death.

Authors:  W J McKenna; J E Deanfield
Journal:  Arch Dis Child       Date:  1984-10       Impact factor: 3.791

9.  Relation between left ventricular gradient and relative stroke volume ejected in early and late systole in hypertrophic cardiomyopathy. Assessment with radionuclide cineangiography.

Authors:  D D Sugrue; W J McKenna; S Dickie; M J Myers; J P Lavender; C M Oakley; J F Goodwin
Journal:  Br Heart J       Date:  1984-12

10.  Hypertrophic cardiomyopathy and associated coronary artery disease.

Authors:  D V Cokkinos; Z Krajcer; R D Leachman
Journal:  Tex Heart Inst J       Date:  1985-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.